[Skip to Content]
[Skip to Content Landing]
Article
January 22, 1910

STATUS OF THERAPY BY ANTIGONOCOCCUS SERUM, GONOCOCCUS BACTERIN AND PYOCYANEUS BACTERIN

Author Affiliations

PHILADELPHIA

From the William Pepper Laboratory of Clinical Medicine. University of Pennsylvania.

JAMA. 1910;LIV(4):258-260. doi:10.1001/jama.1910.92550300001001f
Abstract

The question has arisen in the minds of many of the medical profession, not only throughout the United States, but abroad as well, first, whether or not immunization by bacterins (bacterial vaccines), including tuberculin and serums, is actually valuable and practical for the general practitioner, or whether this method of therapeusis is still a matter of empiricism ; second, whether these therapeutic agents in the pharmaceutical market to-day are safe and trustworthy, or whether they are, like so many proprietary preparations of modern medicine, either wholly or partly inert, or, on the other hand, dangerously potent.

ANTIGONOCOCCUS SERUM AND GONOCOCCUS BACTERIN  As to the value of treatment of gonorrheal infections by one or both of these agents, depending on the particular affection in a given case, there can be no doubt. The experiences of Rogers and Torrey, Swinburne, Perez-Miro, Herbst, Dunavant and others demonstrate the value of antitoxic treatment by the

First Page Preview View Large
First page PDF preview
First page PDF preview
×